Straits Times Index
3,292.69 +10.64 (+0.32%) Nikkei
38,289.02 -116.64 (-0.30%) Hang Seng
17,763.03 +16.12 (+0.09%) FTSE 100
8,144.13 -2.90 (-0.04%) Bitcoin USD
59,938.18 -3,297.41 (-5.21%) CMC Crypto 200
1,288.59 -50.47 (-3.77%)
Kraig Biocraft Laboratories, Inc. (KBLB)
- GlobeNewswire
Kraig Biocraft Laboratories Reports Signing Landmark Agreements in South East Asia
ANN ARBOR, Mich., April 29, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company"), announces today that it has signed key agreements with the Lam Dong Agro-Forestry Research Experiment Center ("LAREC"), the sericulture authority in central Vietnam, pertaining to the rearing and breeding of the Company's specialized silkworm. Within these agreements, Kraig Labs outlined its operational plans for expansion. These agreements outline a collaborative working effort
- GlobeNewswire
Kraig Biocraft Laboratories Successfully Completes Recombinant Cocoon Production From Spring Trials
ANN ARBOR, Mich., April 22, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces today what it considers to be a major milestone. The Company has completed rearing of the first generation of its new BAM-1 parental strains as part of its spring production trial. Kraig Labs has successfully produced cocoon at rates that exceeded all expectations and control parameters for these trials. Under the supervision and guidance of a top indepe
- GlobeNewswire
Kraig Biocraft Laboratories Announces Successful Launch of Spring Production Trials in Southeast Asia for Spider Silk
ANN ARBOR, Mich., April 15, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces today that the spring production trials for the new BAM-1 hybrid have begun and are well on track to meet the Company's expectations and timeline. The Company successfully launched the production trials of BAM-1, its newest and most robust recombinant spider silk production silkworm hybrid, on time and in line with its production roadmap. The Company's C
